The GSVA findings (S3 Fig) indicate that the downregulation of the TSPO gene in AD is linked to pathological mechanisms such as inflammatory responses, neurodegeneration, metabolic disorders, and immune abnormalities. This evidence concerns the gene TSPO and Other metabolic disease.